[1] Costello EK,Lauber CL,Hamady M,et al.Bacterial community variation in human body habitats across space and time[J].Science,2009,326(5960):1694-1697.
[2] Rajilic-Stojanovic M,Heilig,HG,Tims S,et al.Long-term monitoring of the human intestinal microbiota composition[J].Environ Microbiol,2013,15(4):1146-1159.
[3] Huffnagle GB,Noverr MC.The emerging world of the fungal microbiome[J].Trends Microbiol,2013,21(4):334-341.
[4] Hajishengallis G,Liang S,Payne MA,et al.Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement[J].Cell Host Microbe,2011,10(5):497-506.
[5] Kleinegger CL,Lockhart SR,Vargas K,et al.Frequency,intensity,species,and strains of oral Candida vary as a function of host age[J].J Clin Microbiol,1996,34(9):2246-2254.
[6] Ghannoum MA,Jurevic RJ,Mukherjee PK,et al.Characterization of the oral fungal microbiome(mycobiome) in healthy individuals[J].PLoS Pathog,2010,6(1):e1000713.
[7] Mukherjee PK,Chandra J,Retuerto M,et al.Oral mycobiome analysis of HIV-infected patients:identification of Pichia as an antagonist of opportunistic fungi[J].PLoS Pathog,2014,10(3):e1003996.
[8] Hoffmann C,Dollive S,Grunberg S,et al.Archaea and fungi of the human gut microbiome:correlations with diet and bacterial residents[J].PLoS One,2013,8(6):e66019.
[9] Drell T,Lillsaar T,Tummeleht L,et al.Characterization of the vaginal micro-and mycobiome in asymptomatic reproductive-age Estonian women[J].PLoS One,2013,8(1):e54379.
[10] 郑能能,刘伟,漆丽娅,等.复发性念珠菌性阴道炎患者阴道真菌菌群多样性研究[J].浙江预防医学,2012,2(2):13-16.
[11] Paulino LC,Tseng CH,Strober BE,et al.Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions[J].J Clin Microbiol,2006,44(8):2933-2941.
[12] Zhang E,Tanaka T,Tajima M,et al.Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects[J].Microbiol Immunol,2011,55(9):625-632.
[13] Park HK,Ha MH,Park SG,et al.Characterization of the fungal microbiota(mycobiome) in healthy and dandruff-afflicted human scalps[J].PLoS One,2012,7(2):e32847.
[14] Findley K,Oh J,Yang J,et al.Topographic diversity of fungal and bacterial communities in human skin[J].Nature,2013,498(7454):367-370.
[15] Carpagnano GE,Lacedonia D,Palladino GP,et al.Aspergillus spp.colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy[J].BMC Pulm Med,2014,14:22.
[16] Kaewsrichan J,Peeyananjarassri K,Kongprasertkit J.Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens[J].FEMS Immunol Med Microbiol,2006,48(1):75-83.
[17] Hogan DA,Vik A,Kolter R.A Pseudomonas aeruginosa quorumsensing molecule influences Candida albicans morphology[J].Mol Microbiol,2004,54(5):1212-1223.
[18] Noverr MC,Huffnagle GB.Regulation of Candida albicans morphogenesis by fatty acid metabolites[J].Infect Immun,2004,72(11):6206-6210.
[19] Buffo J,Herman MA,Soll DR.A characterization of pH-regulated dimorphism in Candida albicans[J].Mycopathologia,1984,85(1-2):21-30.
[20] Schauber J,Svanholm C,Termen S,et al.Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes:relevance of signalling pathways[J].Gut,2003,52(5):735-741.
[21] Otte JM,Zdebik AE,Brand S,et al.Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity[J].Regul Pept,2009,156(1-3):104-117.
[22] Kinnebrew MA,Buffie CG,Diehl GE,et al.Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense[J].Immunity,2012,36(2):276-287.
[23] Kandori H,Hirayama K,Takeda M,et al.lectinhistochemical and morphometrical characteristics of intestinal goblet cells of germfree and conventional mice[J].Exp Anim,1996,45(2):155-160.
[24] Koh AY,Kohler JR,Coggshall KT,et al.Mucosal damage and neutropenia are required for Candida albicans dissemination[J].PLoS Pathog,2008,4(2):e35.
[25] Smeekens SP,Huttenhower C,Riza A,et al.Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses[J].J Innate Immun,2014,6(3):253-262.
[26] Oh J,Freeman AF,Park M,et al.The altered landscape of the human skin microbiome in patients with primary immunodeficiencies[J].Genome Res,2013,23(12):2103-2114.
[27] Zelante T,Iannitti RG,Cunha C,et al.Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22[J].Immunity,2013,39(2):372-385.
[28] Ivanov II,Atarashi K,Manel N,et al.Induction of intestinal Th17 cells by segmented filamentous bacteria[J].Cell,2009,139(3):485-498.
[29] Atarashi K,Tanoue T,Oshima K,et al.Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota[J].Nature,2013,500(7461):232-236.
[30] Round JL,Lee SM,Li J,et al.The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota[J].Science,2011,332(6032):974-977.
[31] Romani L.Immunity to fungal infections[J].Nat Rev Immunol,2011,11(4):275-288.
[32] De Luca A,Zelante T,D'Angelo C,et al.IL-22 defines a novel immune pathway of antifungal resistance[J].Mucosal Immunol,2010,3(4):361-373.
[33] Sawa S,Lochner M,Satoh-Takayama N,et al.RORgammat+innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota[J].Nat Immunol,2011,12(4):320-326.
[34] Shaw MH,Kamada N,Kim YG,et al.Microbiota induced IL-1 beta,but not IL-6,is critical for the development of steady-state TH17 cells in the intestine[J].J Exp Med,2012,209(2):251-258.
[35] Yin Y,Wang Y,Zhu L,et al.Comparative analysis of the distribution of segmented filamentous bacteria in humans,mice and chickens[J].ISME J,2013,7(3):615-621.
[36] Pandiyan P,Conti HR,Zheng L,et al.CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model[J].Immunity,2011,34(3):422-434.
[37] Bacher P,Kniemeyer O,Schonbrunn A,et al.Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi[J].Mucosal Immunol,2014,7(4):916-928.
[38] Geetha M,Annamma KI,Mathai J,et al.Normal human plasma anti-beta-glucoside antibody has markedly elevated IgA content and binds fungal and yeast polysaccharides[J].Immunol Invest,2007,36(1):73-83.
[39] Mendonca FH,Santos SS,Faria Ida S,et al.Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly[J].Braz Dent J,2012,23(5):534-538.
[40] Montassier E,Batard E,Massart S,et al.16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation[J].Microb Ecol,2014,67(3):690-699.
[41] van Vliet MJ,Harmsen HJ,de Bont ES,et al.The role of intestinal microbiota in the development and severity of chemotherapy induced mucositis[J].PLoS Pathog,2010,6(5):e1000879.
[42] Vicariotto F,Del Piano M,Mogna L,et al.Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product,in women affected by vulvovaginal candidiasis:a pilot study[J].J Clin Gastroenterol,2012,46(Suppl):S73-80.
[43] Zhou X,Westman R,Hickey R,et al.Vaginal microbiota of women with frequent vulvovaginal candidiasis[J].Infect Immun,2009,77(9):4130-4135.
[44] Mazmanian SK.Capsular polysaccharides of symbiotic bacteria modulate immune responses during experimental colitis[J].J Pediatr Gastroenterol Nutr,2008,46(Suppl 1):E11-E12.